Toxemia: Clinical Trials

2 trials for Toxemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2

Follow Toxemia: new trials by email Literature Review of Toxemia trials Research Report on Toxemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
LB1148, Placebo - Septic Shock
Phase 2TerminatedLeading BioSciences, Inc82015-04-012020-06-01
CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB)
CTI-01 (ethyl pyruvate) - Coronary Disease, Heart Valve Diseases
Phase 2TerminatedCritical Therapeutics1502005-04-012006-03-17

Narrower conditions

Coronary Disease (1)  ·  Endotoxemia (1)  ·  Heart Valve Diseases (1)  ·  Hyperlactatemia (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Multiple Organ Failure (1)  ·  Sepsis (1)  ·  Shock (1)  ·  Shock, Septic (1)  ·  Systemic Inflammatory Response Syndrome (1)

Broader conditions

Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Bacteremia (1)  ·  Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Metabolic Diseases (1)  ·  Myocardial Ischemia (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Sepsis (1)  ·  Signs and Symptoms (1)  ·  Systemic Inflammatory Response Syndrome (1)  ·  Vascular Diseases (1)

Interventions

Tranexamic Acid (1)  ·  ethyl pyruvate (1)

Sponsors

Critical Therapeutics (1)  ·  Leading BioSciences, Inc (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Tom Hallam, PhD (1)  ·  Walter Newman, Ph.D. (1)